Literature DB >> 15990286

Recurrence of pulmonary intravascular bronchoalveolar tumor with mediastinal metastasis 20 years later.

Tze-Ming Chen1, Jessica Donington, Gordon Mak, Gerald J Berry, Stephen J Ruoss, Glenn D Rosen, Daya Upadhyay.   

Abstract

Pulmonary intravascular bronchoalveolar tumor (IVBAT) also recognized as pulmonary epithelioid hemangioendothelioma, is a rare malignant vascular tumor of unknown etiology. IVBAT is a tumor of multicentric origin and the lungs are rarely involved, with only about 60 cases of pulmonary IVBAT described in the literature. The prognosis is unpredictable, with life expectancy ranging from 1 to 15 years. We report an unusual case of pulmonary IVBAT that recurred in the lung with metastasis to the mediastinum.

Entities:  

Mesh:

Year:  2005        PMID: 15990286     DOI: 10.1016/j.rmed.2005.05.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Multiple organ metastases of Pulmonary Epithelioid Haemangioendothelioma and a review of the literature.

Authors:  Bo Ye; Wang Li; Xiang-Yang Liu; Ke-Ling Sun; Long-Hai Yang; Ke Ma; Shou-Hua Zhao; You-Sheng Mao
Journal:  Med Oncol       Date:  2009-03-11       Impact factor: 3.064

Review 2.  Pulmonary epithelioid hemangioendothelioma: report of three cases.

Authors:  Torsten Schattenberg; Richard Kam; Michael Klopp; Esther Herpel; Philipp Albert Schnabel; Gunhild Mechtersheimer; Hendrik Dienemann; Joachim Pfannschmidt
Journal:  Surg Today       Date:  2008-08-28       Impact factor: 2.549

Review 3.  Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor.

Authors:  Angela Sardaro; Lilia Bardoscia; Maria Fonte Petruzzelli; Maurizio Portaluri
Journal:  Oncol Rev       Date:  2014-10-13

4.  Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma: A case report and literature review.

Authors:  Zhipeng Zheng; Hanying Wang; Hanliang Jiang; Enguo Chen; Jun Zhang; Xinyou Xie
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.